#Single use Endoscope

[ibsmeditech]

Buy Single-Use Urology Endoscope Step into the future of urology with IBSMeditech's Single-Use Urology Endoscope. Upgrade your procedures, prioritize patient safety, and elevate your practice to new heights and also, Save on maintenance, repair or replacement costs with our single-use endoscope. Visit our website to learn more about our single use urology endoscope and request a demo Click here

[evoendo]

Single-Use Endoscopy System | Single-Use Transnasal Gastroscope, Unsedated Endoscopy

Introducing EvoEndo’s Single-Use Endoscopy System - the innovation that takes endoscopy to the next level! Revolutionize your medical practice with this cutting-edge technology that promises unprecedented convenience, safety, and efficiency.

Experience the power of a single-use system, eliminating the tedious and time-consuming process of reprocessing endoscopes. With our system, you can instantly reduce risks associated with cross-contamination, ensuring the highest level of patient safety.

Say goodbye to expensive repairs and maintenance as our Single-Use Endoscopy System eliminates the need for costly repairs and reduces downtime. You'll save time and money, allowing you to focus on what matters - providing exceptional care to your patients.

Single-Use Endoscopy System is designed to provide crystal-clear imaging, allowing you to perform procedures with unparalleled precision. Our advanced optical technology ensures minimal distortion, enhancing your diagnostic capabilities and improving patient outcomes.

Forget about storage issues and the limited availability of reusable endoscopes. With our single-use solution, you'll have a fresh and sterile endoscope readily available whenever you need it. It's a game-changer for your practice, increasing operational efficiency and patient throughput.

We understand the importance of ease of use in any medical device. That's why our Single-Use Endoscopy System is designed with simplicity in mind. With its user-friendly interface, intuitive controls, and hassle-free setup, you'll be up and running in no time, providing top-quality care to your patients.

Upgrade your endoscopy procedures with EvoEndo’s Single-Use Endoscopy System and enjoy unparalleled benefits - enhanced patient safety, reduced costs, improved image quality, increased efficiency, and effortless usability. Don't miss out on this transformative technology - invest in EvoEndo today and elevate your medical practice to new heights.

Endoscopic Treatment in Adults and Pediatric Patients:

Provide an overview of the applications of endoscopy in adult patients. Discuss how it has become a primary method for diagnosing and treating gastrointestinal conditions such as ulcers, gastrointestinal bleeding, polyps, and even early-stage cancers. Highlight the advantages of endoscopic techniques, such as the ability to perform biopsies, remove tumors or foreign bodies, control bleeding, and more, all while reducing risks and complications. Endoscopy in Patients over Age Five by EvoEndo’s Single-Use Endoscopy System in USA.

About EvoEndo®

EvoEndo®, Inc. is a medical device company developing sterile single-use, flexible endoscopes that enable unsedated endoscopic procedures. EvoEndo’s technology allows pediatric patients and adults alike to consider an unsedated option for routine endoscopies in a clinic setting without the use of general anesthesia or sedation. To learn more, please visit: https://evoendo.com

[alwaysalreadyangry]

colonoscopy today was fine, but the hospital ward had this sign up along with other very interesting colonoscopy-themed christmas decorations…

such as this tree

what are the white decorations, you might ask? the internet says they are “Single-Use Valve Baskets designed for use during decontamination of reusable endoscope valves”. so festive 🎅

Merry colonoscopy time everyone!!!!!!

[snarp]

Cutting to the "shopping list" section:

We focused on using “off the shelf” components and open-source software to develop the wireless endoscope. This significantly lowered the cost with the goal to make the device accessible for resource-constrained environments. While the technology described is applicable to a variety of rigid lens applications, we attempted to replicate the 4 mm cystoscope lens and separately a clip-on universal endoscope camera.

2.1 Hardware systems

A miniature single-board computer (SBC) module the Raspberry Pi Zero W (Raspberry Pi Foundation, Caldecote, UK) was used because of its size, its low cost (US$10) and its ability to handle high-definition (720p) video.

A 3.7-mm tube camera (model: 1001LG, Shenzhen Eastern International Corporation Limited, Shenzhen, China) was used. It delivers 1280 × 720 high-definition video using a 1/7″ colour CMOS sensor. Lens construction allows a wide (115 degree) field of view and an extended depth of field allowing object in the range of 5 to 50 mm to be in focus. Connectivity is via a USB 2.0 interface with the SBC. The camera is certified IP67 waterproof and the manufacturer is ISO 13485:2016 certified for the design and manufacturer of medical endoscope cameras.

Illumination is via 6 high luminous 0603 white colour LEDs incorporated into the tube camera. The system was powered by a 1200mAh lithium polymer battery and incorporated into a fireproof acrylonitrile butadiene styrene enclosure.

For the clip-on wireless camera module, an 18–35 mm optical zoom coupler (Ouman Medical, Jiangsu Ouman Electronic Equipment Co., ltd, Jiangsu, China) and an 8-megapixel camera module (model: IMX219, Arducam) were used.

2.2 Software systems

Open-source Linux software was used on the SBC as follows:

1. The SBC runs on the Raspbian Pi operating system Lite, a minimal image of Debian Buster [9]. 2. The SBC Wi-Fi module is placed in monitor mode (“hotspot”) using RaspAP [10]. This makes wireless video transmission possible. 3. The video signal is streamed via the UV4L module of “Video 4 Linux 2” [11].

4. Lastly, the wireless video signal is viewed on a standard computer via any internet browser. Figure 2 illustrates the entire software setup.

Fig. 2:

[othernaut]

One of my favorite bits of roleplaying is shopping in Shadowrun.

You're literally opening up books full of goodies that you bought, going down lists, reading stats, figuring out what you can use, what you can afford, and it's both so goddamn engaging and so very much in character. You live in a cyberpunk dystopia, they sell tasers at the dollar store, this is both what you are doing and what your characters are doing, all at once.

In the fiction of the game, the gunbunny adept is salivating as hard over the stats of their dream firearms as their player is. The summoner shaman is hemming and hawing over the price of foci, wondering if they can get a discount if they know a guy. The decker is assembling a dream suite of programs and grousing over paying the fees for them, wondering if it'll be more trouble than it's worth to just fucking code the things themselves. The hermetic mage spots an endoscope in the ass end of a gear list and constructs an entire infiltration strategy around it.

Every bit of complexity is as fiddly as it is engaging. The adept lives in a horrible squat because they absolutely require thousands of rounds of specialized ammo to feel safe. The mage dumps half their paycheck into maintaining a clandestine laboratory, the utility of which is determined almost entirely through passing notes to the GM and giggling. The face pays extra to register all their favorite toys under every single one of their half a dozen spare identities. The samurai bought a motorcycle and is determined to spend half an hour of every session tricking it out and tuning it up.

I like storygames as much as anyone. I like fiction-first, I like narrative malleability, I like giving narrative control to players. But there is a narrative inherent in knowing you're five miles underground in the dungeon, you have two torches and 17 arrows left, and you don't have enough rations to make it back to civilization and don't have enough gold to provision yourself if you get there. There is a narrative in looking at a list of things to buy, looking at a building you gotta infiltrate, and going, "All right, we need two microdrones, a bag full of RFID tags with a hole in it, the smallest Force 5 banishing focus we can find, bolt cutters, halloween masks, and at least six blank keycards."

Anyway probably the hottest RPG take I have but anyone who:

thinks there's a dichotomy between roleplaying and "rollplaying" (or roleplaying and combat)

thinks roleplaying is somehow just the "what would my character do" and "what does my character feel" parts of the game

thinks that traditional dungeon crawlers are somehow antithetical to roleplaying

has an incoherent definition of what roleplaying even is. Like, sorry if that comes off as not niceys, but you've got some unexamined elitism towards playstyles you consider beneath you. You don't have to like every style of roleplaying out there but the moment you start saying that X type of game is bad for roleplaying or some shit like that you gotta realize that you just sound like an asshole.

[credenceresearchdotblog]

The Gastric Space Occupying Devices Market is projected to grow from USD 219.2 million in 2024 to an estimated USD 299.99 million by 2032, with a compound annual growth rate (CAGR) of 4% from 2024 to 2032.The global gastric space-occupying devices market has emerged as a significant segment within the broader weight management and obesity treatment sector. These devices, designed to occupy space within the stomach to induce a feeling of satiety, have gained attention as non-invasive alternatives to traditional weight-loss surgeries. With the rising prevalence of obesity worldwide and increasing awareness about minimally invasive solutions, the market for gastric space-occupying devices is poised for substantial growth.

Browse the full report at https://www.credenceresearch.com/report/gastric-space-occupying-devices-market

Overview of Gastric Space-Occupying Devices

Gastric space-occupying devices, such as intragastric balloons, are temporary devices inserted into the stomach to limit food intake by reducing available gastric volume. Typically, these devices are made of biocompatible materials like silicone and are filled with saline or gas. They are generally placed using endoscopic procedures and are removed after a specified duration, usually 6-12 months.

Key products in this market include single and dual intragastric balloons, adjustable balloons, and liquid-filled or air-filled devices. Notable companies such as Apollo Endosurgery, ReShape Lifesciences, and Spatz FGIA are prominent players innovating in this domain.

Market Drivers

Increasing Prevalence of Obesity According to the World Health Organization (WHO), global obesity rates have tripled since 1975. Sedentary lifestyles, unhealthy diets, and genetic predispositions contribute to this trend. Gastric space-occupying devices offer a less invasive and cost-effective solution compared to bariatric surgery, making them appealing to a wider demographic.

Rising Demand for Minimally Invasive Treatments Patients are increasingly opting for minimally invasive procedures that offer shorter recovery times and reduced risks. Gastric space-occupying devices meet these criteria, providing effective weight-loss solutions without the need for permanent surgical alterations.

Technological Advancements Innovations such as adjustable balloons, longer durability, and self-swallowable capsules are expanding the usability and patient compliance of these devices. For example, newer devices like the Elipse Balloon eliminate the need for endoscopic placement and removal, simplifying the procedure.

Growing Awareness and Acceptance Increased awareness of obesity-related health risks, such as cardiovascular diseases and diabetes, has led to higher acceptance of weight-loss interventions. Marketing campaigns and endorsements from healthcare professionals further promote the adoption of these devices.

Challenges and Restraints

While the gastric space-occupying devices market shows promise, it faces several challenges:

High Costs Despite being less expensive than bariatric surgery, these devices are still costly for many patients. Limited insurance coverage for obesity treatments further restricts market growth.

Adverse Effects and Complications Potential side effects, such as nausea, vomiting, abdominal pain, and balloon deflation, may deter patients. Proper training for healthcare professionals and better device designs are essential to address these issues.

Regulatory Hurdles Stringent regulatory requirements can delay product approvals and market entry. Manufacturers must invest significant time and resources in meeting safety and efficacy standards.

Future Outlook

The gastric space-occupying devices market is set to grow at a significant compound annual growth rate (CAGR) over the next decade. Key trends shaping the future include:

Emergence of Non-Endoscopic Devices: Innovations like self-swallowable balloons are expected to simplify procedures and expand patient adoption.

Integration of Digital Health Solutions: Wearable devices and mobile apps for monitoring weight loss and adherence to treatment will enhance patient outcomes.

Focus on Emerging Markets: Manufacturers are targeting regions with rising obesity rates and untapped potential, such as Asia-Pacific and Africa.

Key Player Analysis:

Allurion Technologies, Inc.

Apollo Endosurgery, Inc.

Endalis

Helioscopie

Lexel Medical

MEDSIL

Obalon Therapeutics, Inc.

ReShape Medical, Inc.

Scientific Intake

Segmentation:

By Product:

Gastric Balloons

Oral Palatal Space Occupying Devices

By End-User:

Hospitals

Speciality Clinics

Ambulatory Surgical Centers

By Region:

North America

U.S.

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Spain

Rest of Europe

Asia Pacific

China

Japan

India

South Korea

South-east Asia

Rest of Asia Pacific

Latin America

Brazil

Argentina

Rest of Latin America

Middle East & Africa

GCC Countries

South Africa

Rest of the Middle East and Africa

Browse the full report at https://www.credenceresearch.com/report/gastric-space-occupying-devices-market

Contact:

Credence Research

Please contact us at +91 6232 49 3207

Email: sales@credenceresearch.com 

[global-research-report]

Trends in the Intragastric Balloons Market 2021 - 2028

The global intragastric balloons market size is expected to reach USD 100.2 million by 2028, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 11.9% from 2021 to 2028. The rise in obesity and increasing demand for minimally invasive procedures are anticipated to be key market drivers.

Intragastric balloons are one of the most widely adopted endoscopic bariatric therapy devices in clinical settings. This can be attributed to complications associated with surgical weight loss treatments and the low eligibility criteria for surgical options leading to a rise in demand for effective minimally invasive weight-loss treatment options.

The safety concerns associated with the inflatable medical device are anticipated to make the pre-market and post-market scrutiny process of these devices by the regulatory authorities more stringent. For instance, in 2019, Apollo Endosurgery Inc., revised the labeling of its Orbera Intragastric Balloon System to include contradiction clarifications, precautions related to anticholinergic and psychotropic medications, and updated U.S. adverse event tables after it received an FDA safety letter.

Nonetheless, the extensive research activities related development of innovative and novel systems and up-gradation of existing intragastric balloons to overcome the shortcomings of the traditional inflatable medical devices are anticipated to facilitate market growth.

Intragastric Balloons Market Report Highlights

According to The American Society for Metabolic and Bariatric Surgery (ASMBS) data, nearly 5,000 intragastric balloon implantations have been conducted since their U.S. FDA approval

The single segment held the largest revenue share of the market in 2020 while the triple segment is expected to grow at a fast pace

The gas-filled segment is anticipated to witness lucrative growth over the forecast period

The hospital segment held significant revenue share in 2020 while the ambulatory surgical centers segment is expected to grow at a rapid pace

The endoscopy segment dominated the market in 2020 and the pill form segment is expected to witness lucrative growth over the forecast period

North America dominated the market in 2020 due to the presence of a large obese population and high adoption of bariatric procedures. In Asia Pacific, the market is expected to witness remunerative growth over the forecast period

As of January 2019, Apollo Endosurgery has discontinued the sales and distribution of its ReShape Balloon

Intragastric Balloons Market Segmentation

Grand View Research has segmented the intragastric balloons market on the basis of administration, balloon type, filling material, end use, and region:

Intragastric Balloons Administration Outlook (Revenue, USD Million, 2016 - 2028)

Pill Form

Endoscopy

Intragastric Balloons Type Outlook (Revenue, USD Million, 2016 - 2028)

Single

Dual

Triple

Intragastric Balloons Filling Material Outlook (Revenue, USD Million, 2016 - 2028)

Saline Filled

Gas Filled

Intragastric Balloons End-use Outlook (Revenue, USD Million, 2016 - 2028)

Hospitals

Clinics

Ambulatory surgical centers

Intragastric Balloons Regional Outlook (Revenue, USD Million, 2016 - 2028)

North America

US

Canada

Europe

Germany

UK

France

Italy

Spain

The Netherlands

Belgium

Switzerland

Turkey

Poland

Asia Pacific

Japan

China

India

South Korea

Australia

Thailand

Indonesia

Malaysia

Philippines

Singapore

Latin America

Brazil

Mexico

Argentina

Chile

Colombia

MEA

South Africa

Saudi Arabia

UAE

Israel

Egypt

Order a free sample PDF of the Intragastric Balloons Market Intelligence Study, published by Grand View Research.

[nj-craniofacial-center]

Craniosynostosis Treatment: Helping Your Child’s Skull Develop Normally

Craniosynostosis is a condition where one or more of the sutures in a baby’s skull close prematurely, before the brain is fully developed. This can result in an irregular head shape and may, in some cases, lead to increased pressure on the brain. While the condition can be concerning for parents, craniosynostosis treatment options are highly effective at ensuring a child’s skull and brain develop normally. Early diagnosis and intervention are key to achieving the best outcomes.

Understanding Craniosynostosis

A baby’s skull is made up of several bones connected by sutures—flexible joints that allow the skull to expand as the brain grows. Craniosynostosis occurs when one or more of these sutures close too early. The condition is categorized into two main types:

Non-Syndromic Craniosynostosis: The most common form, occurring without associated genetic syndromes. It typically affects a single suture.

Syndromic Craniosynostosis: Associated with genetic syndromes such as Crouzon, Apert, or Pfeiffer syndromes. This type often involves multiple sutures and may come with other physical abnormalities.

Signs and Symptoms

Parents and pediatricians should watch for the following signs of craniosynostosis:

An irregular or asymmetrical head shape.

A raised, hard ridge along the suture line.

Slow or no growth of the head circumference.

In severe cases, increased intracranial pressure leading to symptoms like irritability, vomiting, or developmental delays.

Diagnosis

A pediatrician or specialist will typically diagnose craniosynostosis through a physical examination of the head shape. Imaging studies such as X-rays, CT scans, or MRIs may be used to confirm the diagnosis and determine the severity of the condition. Genetic testing might also be recommended for syndromic cases.

Read More : Role of Imaging in the Diagnosis of Craniosynostosis and Plagiocephaly in Children

Craniosynostosis Treatment Options

Treatment for craniosynostosis depends on the type and severity of the condition, as well as the child’s age. Below are the most common approaches:

1. Surgery

Surgery is the primary treatment for craniosynostosis. The goal is to correct the head shape, allow for normal brain growth, and relieve any pressure on the brain. Two main surgical options are:

Cranial Vault Remodeling (CVR): This traditional open surgery involves reshaping the skull by removing, reshaping, and repositioning affected bones. CVR is typically performed when the child is between 6 and 12 months old.

Endoscopic Surgery: A minimally invasive option, endoscopic surgery involves removing the fused suture through small incisions. This method is most effective when performed before 6 months of age and is usually followed by helmet therapy to guide skull growth.

2. Helmet Therapy

Helmet therapy is often used following endoscopic surgery to help shape the skull as it heals. The custom-fitted helmet gently redirects skull growth and ensures symmetry. Key points about helmet therapy include:

It is typically worn for 20 to 23 hours a day.

Treatment duration varies but usually lasts several months.

Regular follow-ups are required to adjust the helmet as the child grows.

3. Multidisciplinary Care

For syndromic craniosynostosis, a team of specialists may be involved in the child’s care, including:

Neurosurgeons and craniofacial surgeons for surgical planning and execution.

Geneticists to identify associated syndromes and guide future care.

Pediatricians and developmental specialists to monitor growth and developmental milestones.

Ophthalmologists if the condition affects the eye sockets.

4. Monitoring Mild Cases

In very mild cases of craniosynostosis that do not involve significant brain pressure or cosmetic concerns, close monitoring may be recommended. Regular check-ups with a specialist will help ensure that the skull’s growth is progressing normally.

The Importance of Early Treatment

Timing plays a crucial role in craniosynostosis treatment. The younger the child, the more malleable the bones of the skull are, making surgical correction easier and more effective. Most procedures are performed within the first year of life to maximize the benefits of treatment.

Recovery and Follow-Up Care

After treatment, children typically recover well and achieve normal skull and brain development. Post-operative care includes:

Hospital Stay: Most children spend 1 to 3 days in the hospital for monitoring.

Follow-Up Appointments: Regular visits to the surgical team ensure proper healing and track skull growth.

Helmet Adjustments: If helmet therapy is part of the treatment, frequent adjustments are necessary to accommodate growth.

Parents should watch for any signs of complications, such as swelling, fever, or unusual behavior, and report them to the care team immediately.

Emotional Support for Families

Receiving a diagnosis of craniosynostosis can be overwhelming for parents. Support groups, counseling, and resources from organizations specializing in craniofacial conditions can help families navigate the emotional and practical challenges of treatment.

Final Thoughts

Craniosynostosis treatment is highly effective at addressing both functional and cosmetic concerns associated with the condition. With advancements in surgical techniques and multidisciplinary care, most children go on to lead healthy, normal lives. If you suspect craniosynostosis in your child, consult a pediatric specialist promptly to discuss the best course of action. Early intervention not only corrects head shape but also ensures your child’s brain has the space it needs to grow and thrive.

[lovelypol]

Endoluminal Suturing Devices: Market to Triple by 2033, Driven by 11.5% CAGR

Endoluminal Suturing Devices Market involves the development and distribution of medical devices designed for minimally invasive procedures that enable suturing of tissues within the gastrointestinal (GI) tract. These devices play a critical role in endoscopic surgeries by offering increased precision, reduced recovery times, and improved patient outcomes. The market includes a range of suturing systems, accessories, and advanced technologies aimed at facilitating effective tissue approximation and hemostasis. The demand for less invasive surgical interventions is driving market growth, as healthcare providers strive to enhance patient recovery and operational efficiency.

To Request Sample Report: https://www.globalinsightservices.com/request-sample/?id=GIS24388 &utm_source=SnehaPatil&utm_medium=Article

Market Growth & Trends

The Endoluminal Suturing Devices Market is witnessing significant growth, driven by continuous advancements in minimally invasive surgical techniques. Among the different product categories, automatic suturing devices lead the market due to their efficiency, ease of use, and ability to handle complex procedures. Manual suturing devices follow as the second-largest sub-segment, prized for their precision and control in specialized surgeries. The growing adoption of these technologies reflects a shift toward more efficient and minimally invasive surgical options, which contribute to shorter recovery periods and improved patient outcomes.

Regional Insights

North America holds the largest share of the market, supported by high healthcare expenditure, a rapid adoption of new technologies, and a significant patient population requiring gastrointestinal surgeries.

Europe ranks as the second-leading region, benefiting from a strong healthcare infrastructure, a focus on advanced surgical practices, and an increasing volume of minimally invasive procedures.

Within North America, the United States is the dominant country, driven by innovation in surgical techniques and a large number of surgeries performed annually.

In Europe, Germany stands out as the second-highest performer, fueled by its cutting-edge healthcare system and growing demand for advanced, minimally invasive surgical interventions.

Market Segmentation

By Type:

Disposable

Reusable

By Product:

Endoscopic Suturing Devices

Suturing Accessories

By Application:

Gastrointestinal Surgery

Bariatric Surgery

Gastroesophageal Reflux Disease (GERD) Surgery

Colorectal Surgery

By Technology:

Flexible Endoscopy

Rigid Endoscopy

By End User:

Hospitals

Ambulatory Surgical Centers

Specialty Clinics

By Material Type:

Biodegradable

Non-biodegradable

By Device:

Automated Suturing Devices

Manual Suturing Devices

By Functionality:

Single-use

Multi-use

By Installation Type:

Portable

Stationary

By Solutions:

Innovative Suturing Techniques

Advanced Endoscopic Procedures

Market Volume & Projections

In 2023, the Endoluminal Suturing Devices Market had an estimated volume of 1.2 million units, with projections for continued growth. The flexible endoscopy segment dominates the market, accounting for 45% of the share, owing to its minimally invasive nature and broad application in gastrointestinal surgeries. The rigid endoscopy segment follows with 30%, while the emerging robotic-assisted segment is gaining rapid traction, contributing 25% to the market, driven by technological innovations and increasing adoption in complex procedures.

Key Market Dynamics

This market is seeing dynamic growth with continuous technological advancements, diverse clinical needs, and a focus on minimally invasive surgery. The evolution of endoluminal suturing devices is crucial for improving the precision and efficiency of gastrointestinal surgeries, leading to faster recovery times and better patient care.

#EndoluminalSuturing #MinimallyInvasiveSurgery #EndoscopicSuturing #GastrointestinalSurgery #BariatricSurgery #RoboticSuturing #SurgicalInnovation #Gastroenterology #AdvancedEndoscopy #MedicalDevices #SuturingTech #HealthcareInnovation #SurgicalPrecision #PatientOutcomes #SuturingSolutions #FlexibleEndoscopy #AdvancedSurgicalDevices #GastrointestinalHealth

[evoendo]

Exploring the Benefits and Applications of Endoscopic Treatment in Adults and Pediatric Patients

Introduction:

Endoscopy, a minimally invasive procedure, has revolutionized medical diagnostics and treatment options for patients of all ages. This blog post will delve into the world of endoscopic treatment and explore its benefits, applications, and advancements in both adult and pediatric patients. 

Endoscopic Treatment in Adults and Pediatric Patients:

Provide an overview of the applications of endoscopy in adult patients. Discuss how it has become a primary method for diagnosing and treating gastrointestinal conditions such as ulcers, gastrointestinal bleeding, polyps, and even early-stage cancers. Highlight the advantages of endoscopic techniques, such as the ability to perform biopsies, remove tumors or foreign bodies, control bleeding, and more, all while reducing risks and complications. Endoscopy in Patients over Age Five by EvoEndo’s Single-Use Endoscopy System in USA. 

Endoscopic Treatment in Pediatric Patients:

Shift focus to pediatric patients and explore how endoscopy has transformed the treatment landscape in this population. Discuss how endoscopy is used to diagnose and manage a range of conditions in children, including gastrointestinal disorders, respiratory issues, and urological abnormalities. Include information about specialized endoscopic procedures developed specifically for pediatric patients and their benefits.

Advancements in Endoscopic Technology:

Highlight the latest advancements and trends in endoscopic technology that have improved diagnostic accuracy and treatment outcomes. Discuss innovations such as high-definition imaging, robotic-assisted endoscopy, and therapeutic tools, which enable healthcare professionals to perform complex procedures with precision and efficiency.

Benefits and Risks of Endoscopic Treatment:

Provide a comprehensive overview of the benefits patients can expect from endoscopic treatment, such as reduced pain, shorter hospital stays, and faster recovery times. Additionally, addresses potential risks and complications associated with the procedure, ensuring readers are well-informed before considering endoscopy.

The Role of Endoscopic Treatment in the Future:

Explore the potential future developments in the field of endoscopy. Discuss ongoing research and emerging techniques that aim to further enhance the diagnostic and therapeutic capabilities of endoscopic procedures. Predict how these advancements may improve patient outcomes and revolutionize medical interventions.

EvoEndo’s Single-Use Endoscopy System represents a major advancement in the field of endoscopy. With its cost-effectiveness, time-saving benefits, elimination of contamination risks, and improved patient care outcomes, this innovative technology is revolutionizing the way endoscopic examinations are conducted. 

About EvoEndo®

EvoEndo®, Inc. is a medical device company developing sterile single-use, flexible endoscopes that enable unsedated endoscopic procedures. EvoEndo’s technology allows pediatric patients and adults alike to consider an unsedated option for routine endoscopies in a clinic setting without the use of general anesthesia or sedation. To learn more, please visit: https://evoendo.com

[ottomed]

How Endoscopy Software is revolutionizing diagnostic and surgical procedures

At Ottomed, we hold ourselves to the highest standard and believe in full transparency within our team and with our customers. Therefore, our production process includes rigorous practices and procedures to ensure the best possible result. Simply selling products has never been enough. That's why we've taken the time and effort to ensure our production process is geared to the highest level possible.

At Ottomed, we aim to make high-quality life care products and services available and affordable for everyone. We're committed to constant innovation and bringing you the best-in-class products. Ottomed Endoscopy is a Mitra Medical Services LLP division in the Mitra Group.

Next-Generation Endoscopy Systems

Smart Eye-II Plus is a Class 1 Next-Generation Digital Video Endoscopy Software offering best-in-class features to Gastroenterologists. HD+ platform with super bright LED-At-Tip light source, Tactile Insertion Tube (TIT), Touch screen Interface, and Extreme Close-Up Endoscopy (eCUE) technology makes diagnostic and therapeutic endoscopic treatments smooth & hurdle free.

Top Features: 

mBLU Imaging

mBLU Imaging is an advanced optical & light sensor technology that increases the detection/characterization of lesions/polyps by depicting brighter and clearer endoscopic images. The mBLU system utilizes two modes:

mBLU Mode 1 - suitable for the microvascular pattern.

mBLU Mode 2 - suitable for Detection.

​

The mBLU system's diagnostic ability allows for the more accurate discrimination of adenomas from non-adenomatous lesions than conventional white light. Further studies can be made to validate these observations.

2. Super bright LED-At-Tip

Thanks to the new phosphor coating on the LED substrate, you can experience 3x brightness and 15% wider spread, supporting high reliability over years of use. The patented Ottomed LED-At-Tip technology does away with the fragile light guide glass fiber bundle, making the Ureteroscope sturdy and environmentally friendly. They also have a long life, superior light intensity, low maintenance, and low replacement costs.

3. Touch screen Interface

Smart Eye-II Plus video processor has intuitive and easy-to-use Touch-Screen Interface technology, which makes using it simple and helps to accelerate endoscopy procedures. The simple user interface has all operations on one screen, making it easier for the nurse and technical staff and improving procedure efficiency.

4. ​Ultra-Lightweight Waterproof Connector

The ultra-lightweight and fully immersive waterproof connector makes a single-handed, single-click connection easy and simple. The waterproof connector also makes the endoscope more reliable and user-friendly.

5. Video Signal I/O

Multiple Digital and analog video I/O signals connectivity help connect the video system to multiple displays, recording software and devices, and long-distance video transmission.

6. Compact & Light Weight

LED at Tip technology helps to make the System compact & lightweight. Easy to carry anywhere.

​

[jcsmicasereports]

The frequency and management of CBD stones in a Pediatric Series by Dr.Anies Mahomed in Journal of Clinical Case Reports Medical Images and Health Sciences

Background: The prevalence of cholelithiasis in children is rare and a fraction of these will also have concomitant choledocholithiasis. Detection and expeditious management of common bile duct (CBD) stones is critical to avoiding complications, some of which are potentially life threatening. Of concern are, obstructive jaundice, recurrent pancreatitis and ascending cholangitis. The management options for CBD stone are multiple and extraction can be achieved via, open choledochotomy, endoscopic retrograde cholangiography (ERCP) with sphincterotomy, choledochoscopy and percutaneously via transhepatic cholangiography (PTC).

Aim: To evaluate the epidemiology, associated comorbidity and management of CBD stones in children. To focus on the effectiveness of ERCP with sphincterotomy, in this context, and, the timing of cholecystectomy

Method: A retrospective review of a prospectively recorded series of CBD stones over a 20 year period (2003-2023) in three, tertiary pediatric surgical centers, was undertaken. These were, The Royal Alexander Children’s Hospital, Brighton, UK, between 2003 and 08/2015, King Faisal Specialist Hospital and Research Center (KFSHRC), Jeddah, from 2010 to 2020, and KFSHRC Medinah (2021-23). Data was collected prospectively in Excel (Microsoft) and a bespoke, expanded medical audit system (EMAS) database. A subgroup with CBD stones was identified preoperatively, from clinical presentation, biochemistry (Liver function tests) and radiological investigations (ultrasound and MRCP). Patient demographic data, presentation, investigations, details of intervention and outcome were documented. 

Result: A total of 67 cases underwent laparoscopic cholecystectomy during the period of study. CBD Stones were suspected in 20 patients and confirmed in 13(19.4 %). The mean age of this sub-group was 8 years (range of 4-16 years) with a female to male ratio of 2:1. Nine patients had associated hemoglobinopathies (three sickle cells anemia, two each with erythropoeitic porphyria and hemophagocytic lymphohistiocytosis, and single cases of sickle thalassaemia and hereditary spherocytosis). Seven presented with obstructive jaundice all with confirmed CBD stones on workup. A single case presented with jaundice and insulin dependent diabetes following 3 previous pancreatectomy for nesidioblastosis. Nine patients presented with a history of pancreatitis of which three were positive for CBD stones. Three had a history of cholangitis of which 2 were found to have CBD stones. All cases had right upper quadrant pain. Alkaline phosphatase was elevated in 6 cases with obstructed jaundice and, or, cholangitis. AST and ALT values were variable and uncorrelated to clinical presentation. All patients underwent ultrasound scans of which 13 demonstrated CBD stones. MRCP was undertaken in 12 of the 67 cases who underwent cholecystectomy and CBD stones were discovered in 4 cases with another patient suspected to have a diverticulum of the CBD. Seven patients of the 20 were investigated and cleared of CBD stones and proceeded to laparoscopic cholecystectomy. Of these, two underwent intraoperative cholangiography, one with an incidentally discovered impacted cystic duct stone at operation and the other a suspected CBD diverticulum on MRCP. Both cases had a normal biliary tree. The cystic duct stone was successfully dis-impaction in the former and the stone extracted in a retrieval bag.

All patients with CBD stones underwent initial ERCP and successful stone extraction. Five patients had stent placements. A single patient had a previous failed attempt at ERCP and stone extraction in another center. A stent was placed and he was referred to us where a repeat sphincterotomy and stone clearance with cholecystectomy was successfully executed. Eleven patients had interval laparoscopic cholecystectomy within 2 months of stone clearance and were uncomplicated. One case had cholecystectomy, a day following ERCP, at the same admission. Our most recent case had a combined ERCP, sphincterotomy, and stone extractio with cholecystectomy under the same anesthetic. Those patients having previous ERCP and stent placements were noted to be surgically more challenging on account of extensive peri-cholecystic and choledochal inflammation with adhesions. The cystic duct was markedly dilated in three cases necessitating either vicryl endoloop or vascular endoclip application for control of the cystic duct. One case with previous pancreatitis and intermittent abdominal pain was discovered, intraoperatively, to have a hypermobile caecum and underwent a caecopexy at the time of cholecystectomy. Median post-operative stay was one day and there were no post-operative complications. Patients were followed up for a median of 2 years and no recurrence of CBD stones were documented.

Discussion: Biliary obstruction whether from benign or malignant causes, is rarely seen in children. The most common benign causes of biliary obstruction are choledochal cyst, biliary atresia, and CBD stones. Although rare, Rhabdomyosarcoma is the most frequent of the malignant causes of CBD occlusion. CBD stones are seen in up to 10 percent of patients with gallstones and its frequency is rising. The reason for this are multifactorial and increased incidental detection during radiological investigations and a rise in obesity levels are sited. 1,2 A significant number of these patients will have associated co-morbidities and figures up to 79.3% are quoted.1 Listed among these are hemolytic disorders, obesity, post bariatric surgery, portal hypertension, pulmonary disease, total parenteral nutrition (TPN), hepatocellular disease, bacterial infection, biliary tract anomalies and short bowel syndrome.1-7 In our experience 55 % of patients had identifiable co-morbidities, the majority with hemaglobinopathies with a single case of insulin dependent diabetes following near total, pancreatectomy for nesidioblastosis. CBD stone should be suspected when patients present with a history of jaundice, pancreatitis, rigors and right upper quadrant pain. Except for those with active jaundice, pancreatitis and cholangitis serological investigations at the time of admission are often normal. However, bilirubin and ALP levels have the highest specificity and will be elevated in nearly all cases with obstructive jaundice. We found no trend to the ALT and AST levels in these cases. Ultrasonography, with a sensitivity over 85 %, is a useful initial diagnostic tool in detecting CBD stones. Additional findings may include, CBD dilatation, cholelithiasis and pancreatic pseudocyst in those with a history of pancreatitis. 1,4 MRCP is a useful complement to ultrasonography as it oers a physiological evaluation of the CBD. It is also noninvasive, quick and with no risk of exposure to ionizing radiation. In adults, MRCP is able to detect the presence and level of biliary obstruction with a sensitivity over 90 % and a specicity approaching 100 %. 8,9,10,11

If both US and MRCP are negative, then ERCP is probably not indicated. Seven of the cases in our series did not proceed to ERCP and did not subsequently manifest with CBD stones. The remainder, which were detected by either US and/or MRCP proceeded to ERCP. All had successful documentation and extraction of CBD stones, one patient at a second attempt where sphincterotomy was extended and the sphincter of Oddi, balloon dilated to 10mm. ERCP has been successfully reported in older children but there is still debate about its safety and efficacy in those less than two years of age. The procedure requires a high level of expertise and specific scopes which are not widely available. Our youngest patient was 2 years of age but there is a reported case of a CBD stone extracted at ERCP in a patient less than 8 months old. ERCP is usually performed together with sphincterotomy although balloon dilatation of sphincter of Oddi with stone extraction has been described. We found ERCP to be completely safe but complications of post-ERCP pancreatitis (7.7 %), immediate and delayed sphincterotomy bleed, and CBD injury, have been noted. 12 All cases are performed under general anaesthesia although conscious sedation has been attempted. The latter is not without risk and has led to premature discontinuation of the procedure with failure or conversion to general anesthesia in 7.1 % of cases. 13

In preference to the above approach, some centers preferentially recommend routine intraoperative cholangiogram(IOC).3,8 We undertook IOC in two instances, a case of an impacted cystic duct stone incidentally noted at the time of cholecystectomy and for a suspected diverticulum in the distal CBD noted on MRCP. Both times the anatomy of the CBD was confirmed to be normal. The success rate of intraoperative cholangiogram and stone extraction using a choledochoscope aided by Dormia basket or Fogarty catheter is 72%. 3,4,14 IOC has a false positivity rate of 20-25% in children. In addition to its low yield, factors of cost and extended operative time need to be considered. Furthermore, intra and post-operative morbidity rates of 6.3 and 15.9 percent respectively have been reported. 1 A less popular alternative to the above has been a percutaneous transhepatic approach used in combination with dilatation of the sphincter of Oddi. The CBD stone is then either retrieved or coaxed into the duodenum. 15 The use of open choledocotomy and stone extraction has receded as the laparoscopic approach has gained in popularity.

The timing of laparoscopic cholecystectomy relative to ERCP and stone extraction is flexible. Most units prefer to undertake cholecystectomy at the same admission, with some deferring to a later date. 16,17 Recently we have started to undertake both ERCP stone extraction and cholecystectomy under the same anesthetic. The benefits are multiple and principle among these are the cost and time saving as well as avoiding the risks of multiple anesthetic for the patient. Thus far we have had no complications with combining these interventions and have adopted this as the preferred approach in children. A recent meta-analysis of an adult series, demonstrated clear benefit of cholecystectomy post ERCP on the same day or within 3 days of surgery. These patients enjoyed shorter length of hospital stay with quicker operative time and a lower risk of complications. 17

[johngarrison1517]

One Sensor, Infinite Possibilities: The Gige Camera Journey

Have you ever wondered how technology can revolutionize your operations in ways you didn’t imagine? What if a single sensor could open a world of possibilities, transforming industries ranging from manufacturing to healthcare, security to research? With GigE cameras, that "what if" has become a reality. But how can such a compact and powerful tool make a difference in your daily work? And how do GigE cameras tackle the challenges you face in capturing, processing, and transmitting high-resolution images or video?

Welcome to the fascinating journey of the GigE camera – the game-changing technology you didn’t know you needed but can’t afford to overlook. In this blog, we’ll explore the key benefits of GigE cameras, addressing the pain points they solve and showcasing how they can take your operations to the next level. Let’s dive in!

The Challenge of High-Speed Data Transmission

In today’s fast-paced world, data transmission speed and image clarity are more critical than ever. Whether you’re involved in industrial automation, scientific research, security, or healthcare, slow image transfer and laggy performance can hinder productivity and delay decision-making. For businesses, every second counts. A camera that can seamlessly transmit large volumes of data without compromising quality becomes a crucial part of the operation.

This is where GigE cameras shine. With their ability to deliver high-speed data transfer via Ethernet, they help businesses overcome slow or unreliable image capture systems. Unlike traditional USB cameras, which may encounter bandwidth bottlenecks when transmitting large images or high-definition video, GigE cameras maintain speed and stability, even with complex imaging needs.

GigE cameras use Gigabit Ethernet for data transmission, which means they can move vast amounts of data quickly without losing signal integrity over long distances. Imagine the freedom of real-time, high-resolution video streaming or imaging in environments where other cameras would lag. With GigE, you no longer have to sacrifice speed for quality or vice versa.

Scalability: The Camera That Grows With Your Business

Another common challenge for industries today is scalability. As your business or project grows, your imaging needs grow too. What works for a small setup may not cut it as you expand. With GigE cameras, scalability is built right into the design. These cameras can be networked together, making it easy to scale up your system without major rewiring or infrastructure changes.

In high-demand environments, such as factories or research labs, having a camera system that can seamlessly scale with new machines or projects saves both time and money. GigE cameras allow you to add more devices without needing to redesign your setup entirely. For businesses in manufacturing, retail, and beyond, this flexibility leads to smoother operations and fewer headaches.

Versatility Across Industries

Perhaps one of the most exciting aspects of GigE cameras is their versatility. These cameras aren’t just for one industry or one specific need – they are used across a wide range of applications. Let’s take a look at a few examples:

Industrial Automation: GigE cameras are widely used in assembly lines and quality control processes. Their speed and precision make them ideal for inspecting components and ensuring products meet the required standards, all while transmitting data in real-time for immediate feedback.

Security and Surveillance: In security, clarity and coverage are paramount. GigE cameras provide high-resolution video feed, even over long distances, ensuring that no detail goes unnoticed. Whether monitoring large spaces or critical areas, GigE cameras ensure you stay ahead of potential threats.

Healthcare: For medical imaging and diagnostics, clarity is non-negotiable. GigE cameras support high-definition imaging, delivering crisp, detailed visuals for procedures like endoscopy, microscopy, and more, enabling accurate diagnoses and treatment decisions.

Scientific Research: In research settings, GigE cameras provide precise imaging for experiments and studies, transmitting data instantly for analysis. From environmental monitoring to astronomy, GigE cameras enhance data collection and interpretation, making them a key tool in the research world.

By addressing the unique needs of each industry, GigE cameras demonstrate their ability to serve a multitude of purposes, transforming processes that were previously complex or inefficient.

Simplified Integration and Maintenance

The fear of complicated setups or long-term maintenance is another hurdle many businesses face when implementing new technology. GigE cameras, however, are designed with ease of integration in mind. Their compatibility with various software platforms and devices means that setting up these cameras is typically a straightforward process. Furthermore, their use of Ethernet networks means that companies can take advantage of their existing infrastructure, saving both time and money on installation.

Once in place, GigE cameras require minimal maintenance. The robust design and industry-standard connectors ensure long-term reliability, even in harsh environments. The ability to connect directly to a network also simplifies remote monitoring and troubleshooting, allowing businesses to quickly identify and resolve issues without needing on-site visits.

Cost-Effective Performance

It’s easy to assume that such advanced technology would come with a hefty price tag. But in reality, GigE cameras are often more affordable than you might think. When factoring in their longevity, low maintenance requirements, and ability to handle a wide variety of tasks, these cameras deliver exceptional value for businesses. Whether you need them for a specialized task or as part of an integrated system, GigE cameras offer a cost-effective solution that doesn’t compromise on performance.

The Future of Imaging

As technology continues to evolve, the potential of GigE cameras will only expand. Innovations in camera sensors, AI integration, and machine learning will make these cameras even smarter, offering automated analysis and data processing capabilities that can save businesses time and resources. The future of imaging with GigE cameras is one where you can capture the finest details, analyze data more efficiently, and automate processes that once required human intervention.

Revolutionize Your Operations with GigE Cameras

Are you ready to unlock the potential of GigE cameras and take your business operations to the next level? Whether you’re looking to enhance quality control, improve surveillance capabilities, or enable advanced research, GigE cameras provide the tools you need to succeed. Their high-speed data transfer, scalability, versatility, and cost-effectiveness make them a powerful asset for industries across the board.

Don't let outdated technology hold you back. Embrace the future of imaging with GigE cameras and experience the difference it can make for your business today. Contact us to explore our range of GigE camera solutions and discover how we can help you revolutionize your operations.

[farmacuticals]

Exploring the Algae Supplements Market: Key Drivers and Emerging Opportunities

An Automated Endoscopy Reprocessor (AER) is a specialized machine designed to disinfect and sterilize endoscopes and other flexible medical instruments, providing an efficient and reliable alternative to manual cleaning. As the demand for endoscopic procedures has increased due to rising cases of gastrointestinal, respiratory, and urinary diseases, the importance of safe, efficient reprocessing methods like Automated Endoscopy Reprocessors has grown. AERs ensure that the devices are disinfected according to high medical standards, reducing the risk of cross-contamination and infection between procedures. These systems offer consistent, controlled cleaning cycles that minimize human error, helping healthcare facilities adhere to strict infection control guidelines.

The Automated Endoscopy Reprocessor Market Size was projected to reach 1.36 billion USD in 2022, according to MRFR analysis. By 2032, the market for automated endoscopy reprocessors is projected to have grown from 1.47 billion USD in 2023 to 2.8 billion USD. During the projected period (2024-2032), the Automated Endoscopy Reprocessor Market is anticipated to grow at a CAGR of approximately 7.45%.

Automated Endoscopy Reprocessor Size and Market Share

The Automated Endoscopy Reprocessor market has seen steady growth in recent years, reflecting the expanding usage of endoscopic procedures globally. Market size is influenced by several factors, including healthcare providers’ focus on infection prevention, advancements in healthcare infrastructure, and the growing awareness about patient safety. In terms of market share, leading manufacturers such as Olympus, Medivators, and Getinge have dominated the market due to their advanced product offerings and established distribution networks. However, the market also includes new entrants bringing innovative solutions to Automated Endoscopy Reprocessor technology, contributing to the market’s size and competitive landscape. The demand for compact, space-saving models has also increased, particularly in smaller healthcare facilities where space constraints are a concern.

Automated Endoscopy Reprocessor Analysis

Analyzing the Automated Endoscopy Reprocessor market involves looking at current trends, regulatory factors, technological advancements, and the regional demands that shape its growth. Technological advancements such as touchscreen interfaces, automated reporting, and reduced cycle times are significant drivers. Additionally, compliance with regulatory bodies like the FDA and ISO is crucial, as these organizations set stringent standards for disinfection processes to ensure patient safety. Regional factors also play a role; for instance, the North American market has seen a high adoption rate due to stringent healthcare regulations, while emerging markets in Asia-Pacific are expected to see growth due to increased healthcare investments and rising awareness of infection control practices.

Automated Endoscopy Reprocessor Trends

Several key trends are currently shaping the Automated Endoscopy Reprocessor market. Firstly, there is a growing demand for eco-friendly and energy-efficient systems as healthcare providers look to reduce their environmental impact. Secondly, automated data tracking and digital connectivity have become more prevalent, allowing facilities to monitor and document disinfection cycles for compliance purposes. Thirdly, the shift toward single-use devices in some regions impacts the AER market, although reusable devices remain prevalent in many areas due to cost efficiency. Additionally, there is an increased focus on user-friendly interfaces and quick turnaround times, which help improve workflow efficiency in busy healthcare settings. These trends indicate a movement toward smarter, safer, and more efficient disinfection systems.

Reasons to Buy the Reports

Gain comprehensive insights into the Automated Endoscopy Reprocessor market, including market size, share, and key growth drivers.

Understand the latest Automated Endoscopy Reprocessor trends, from technological advancements to regulatory factors that influence purchasing decisions.

Access detailed Automated Endoscopy Reprocessor analysis, helping stakeholders make informed investment and strategy decisions.

Learn about recent developments and innovations in the AER market, including environmentally friendly options and smart connectivity features.

Benchmark leading players and assess potential new entrants to understand competitive dynamics in the Automated Endoscopy Reprocessor landscape.

Recent Developments in the Automated Endoscopy Reprocessor Market

Recent advancements in the Automated Endoscopy Reprocessor market include the introduction of devices that support rapid cycle times, allowing for quicker patient turnover in busy healthcare environments. Companies are also focusing on the development of AER systems with integrated data logging and remote monitoring capabilities, which allow facilities to track reprocessing data in real-time and ensure compliance with regulations. Additionally, manufacturers have responded to market demands for compact models that fit smaller facilities without compromising on performance. Sustainability has been another area of focus, with companies like Getinge releasing AER models that use lower amounts of water and chemicals, reducing the overall environmental impact of the reprocessing process. These advancements indicate an ongoing trend toward efficient, eco-friendly, and data-centric reprocessing solutions that cater to the needs of modern healthcare facilities.

In summary, the Automated Endoscopy Reprocessor market is evolving to meet the increasing demand for safe, effective, and efficient disinfection solutions, driven by trends in digital connectivity, environmental sustainability, and enhanced performance.

Relate reports:

pelvic floor stimulator market

pharmaceutical solvent market

plastic surgery instrument market

Top of Form

Bottom of Form

[gis56]

"Market Dynamics 2024-2033: The Disposable Endoscopes Evolution"

Disposable Endoscopes Market : Disposable endoscopes are revolutionizing the healthcare industry by enhancing both patient safety and clinical efficiency. Unlike traditional reusable endoscopes, which require extensive cleaning and sterilization processes, disposable endoscopes eliminate the risk of cross-contamination and infections. This advancement ensures that every patient benefits from a sterile device, reducing complications and improving overall outcomes. Additionally, disposable endoscopes offer a cost-effective solution for healthcare facilities by minimizing the need for expensive sterilization equipment and labor, while also speeding up turnover times between procedures.

To Request Sample Report : https://www.globalinsightservices.com/request-sample/?id=GIS25892 &utm_source=SnehaPatil&utm_medium=Article

The adoption of disposable endoscopes is growing rapidly, especially in high-risk areas like bronchoscopy, urology, and gastrointestinal procedures. These single-use devices are also lightweight, highly portable, and designed with the latest imaging technology, ensuring precise diagnostics and improved accessibility in remote or emergency settings. As healthcare continues to prioritize patient safety and efficiency, disposable endoscopes are set to become the gold standard for endoscopic procedures.

#DisposableEndoscopes #PatientSafety #HealthcareInnovation #Endoscopy #MedicalDevices #InfectionControl #CrossContamination #SterileEquipment #HealthTech #SurgicalEfficiency #MedicalAdvancements #Bronchoscopy #Gastroenterology #SingleUseDevices #UrologyTech